MEDAMI 2022 - Multimodality molecular neuro-imaging: clinical and technical state-of-the-art

Session

Tracers and other modalities

Session 2

5 Sept 2022, 10:40

Conveners

Tracers and other modalities

• Vesna Sossi

70. Molecular imaging in dementia

Gilles Allali

05/09/2022, 10:40

Invited Virtual

Molecular imaging is key in dementia, especially for early diagnosis, but also for identifying reversible forms of dementia. The objective of this presentation is to give the clinical perspective of molecular imaging for improving the early diagnosis of dementia and to explain how it may help to improve the diagnosis of reversible dementia. We will use the recent development of a new clinical...

2. What we really need in the clinic

John Olivier Prior, John Prior

05/09/2022, 11:10

Degeneration, Addiction And Trauma

Invited Virtual

53. Data harmonization

Gitte Moos Knudsen

05/09/2022, 11:40

Tracers and other modalities

Invited Virtual

4. Tradeoffs between Full Kinetic Modeling and Simplified Approaches in Neuropsychiatric PET

Richard Carson (Yale University)

05/09/2022, 12:10

Tracers and other modalities

Invited Virtual

PET imaging allows the production of high resolution images of radiopharmaceutical distribution in humans and animals. With the use of appropriate radiopharmaceuticals combined with tracer kinetic modeling, relevant physiological parameters such as volume of distribution (VT) and binding potential (BPND) can be quantified in vivo. The development of appropriate modeling methodology typically...